Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 5.71864165 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.71864165 |
3 | ribosomal small subunit assembly (GO:0000028) | 4.96433408 |
4 | protein localization to endosome (GO:0036010) | 4.81033482 |
5 | proteasome assembly (GO:0043248) | 4.73113940 |
6 | DNA deamination (GO:0045006) | 4.72260838 |
7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.27564925 |
8 | termination of RNA polymerase III transcription (GO:0006386) | 4.25813585 |
9 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.25813585 |
10 | barbed-end actin filament capping (GO:0051016) | 4.25705889 |
11 | purine nucleobase biosynthetic process (GO:0009113) | 4.23367445 |
12 | maturation of SSU-rRNA (GO:0030490) | 4.22986049 |
13 | protein retention in ER lumen (GO:0006621) | 4.22538416 |
14 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.20494126 |
15 | 7-methylguanosine mRNA capping (GO:0006370) | 4.13340755 |
16 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.07571494 |
17 | 7-methylguanosine RNA capping (GO:0009452) | 4.07566061 |
18 | RNA capping (GO:0036260) | 4.07566061 |
19 | skin morphogenesis (GO:0043589) | 4.06610702 |
20 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.02888539 |
21 | nucleobase biosynthetic process (GO:0046112) | 4.00149227 |
22 | pinocytosis (GO:0006907) | 3.98461697 |
23 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.98386175 |
24 | cullin deneddylation (GO:0010388) | 3.97869466 |
25 | protein deneddylation (GO:0000338) | 3.90536195 |
26 | ribosome assembly (GO:0042255) | 3.89954856 |
27 | ribosomal small subunit biogenesis (GO:0042274) | 3.88088752 |
28 | negative regulation of ligase activity (GO:0051352) | 3.80943756 |
29 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.80943756 |
30 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.79471234 |
31 | ribosomal large subunit biogenesis (GO:0042273) | 3.76322846 |
32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74704159 |
33 | CENP-A containing nucleosome assembly (GO:0034080) | 3.73746908 |
34 | rRNA modification (GO:0000154) | 3.68341085 |
35 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.67359864 |
36 | mitotic metaphase plate congression (GO:0007080) | 3.65894645 |
37 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.64849037 |
38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.63423683 |
39 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.61850861 |
40 | DNA replication checkpoint (GO:0000076) | 3.61507115 |
41 | formation of translation preinitiation complex (GO:0001731) | 3.60953750 |
42 | DNA replication initiation (GO:0006270) | 3.58934347 |
43 | viral transcription (GO:0019083) | 3.58704257 |
44 | translational termination (GO:0006415) | 3.58105109 |
45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.58037049 |
46 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.54988556 |
47 | DNA strand elongation (GO:0022616) | 3.54951089 |
48 | transcription from RNA polymerase I promoter (GO:0006360) | 3.53523297 |
49 | ribosome biogenesis (GO:0042254) | 3.52537726 |
50 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.52469362 |
51 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.52469362 |
52 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.52469362 |
53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.51679597 |
54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.51679597 |
55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.50422923 |
56 | regulation of early endosome to late endosome transport (GO:2000641) | 3.49983795 |
57 | chromatin remodeling at centromere (GO:0031055) | 3.48563266 |
58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.47398596 |
59 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46183733 |
60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.42672349 |
61 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.42672349 |
62 | termination of RNA polymerase I transcription (GO:0006363) | 3.42657414 |
63 | positive regulation of ligase activity (GO:0051351) | 3.42549660 |
64 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.42244376 |
65 | stress fiber assembly (GO:0043149) | 3.40720146 |
66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.40536013 |
67 | cotranslational protein targeting to membrane (GO:0006613) | 3.38114257 |
68 | telomere maintenance via recombination (GO:0000722) | 3.37680409 |
69 | viral mRNA export from host cell nucleus (GO:0046784) | 3.37587242 |
70 | rRNA processing (GO:0006364) | 3.36644195 |
71 | protein maturation by protein folding (GO:0022417) | 3.34851512 |
72 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.34568326 |
73 | protein targeting to ER (GO:0045047) | 3.33146858 |
74 | pentose-phosphate shunt (GO:0006098) | 3.31925313 |
75 | cell-substrate junction assembly (GO:0007044) | 3.31866967 |
76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.30099271 |
77 | translational elongation (GO:0006414) | 3.27372887 |
78 | focal adhesion assembly (GO:0048041) | 3.26141216 |
79 | cell-substrate adherens junction assembly (GO:0007045) | 3.26141216 |
80 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.26033013 |
81 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.26033013 |
82 | basement membrane organization (GO:0071711) | 3.25932594 |
83 | translational initiation (GO:0006413) | 3.23780168 |
84 | peptidyl-histidine modification (GO:0018202) | 3.23426223 |
85 | spliceosomal snRNP assembly (GO:0000387) | 3.22253266 |
86 | rRNA metabolic process (GO:0016072) | 3.20608355 |
87 | adherens junction assembly (GO:0034333) | 3.20539522 |
88 | cell adhesion mediated by integrin (GO:0033627) | 3.20335110 |
89 | protein localization to endoplasmic reticulum (GO:0070972) | 3.20174665 |
90 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.19656107 |
91 | translation (GO:0006412) | 3.18819118 |
92 | cellular component biogenesis (GO:0044085) | 3.18020845 |
93 | metaphase plate congression (GO:0051310) | 3.17280089 |
94 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.16559268 |
95 | pseudouridine synthesis (GO:0001522) | 3.15776484 |
96 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15521433 |
97 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.14309731 |
98 | cell cycle G1/S phase transition (GO:0044843) | 3.14309731 |
99 | mitotic recombination (GO:0006312) | 3.14215427 |
100 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.13455953 |
101 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.11763755 |
102 | hemidesmosome assembly (GO:0031581) | 3.07126818 |
103 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.06714570 |
104 | response to peptidoglycan (GO:0032494) | 3.05021632 |
105 | regulation of ligase activity (GO:0051340) | 3.04853711 |
106 | amino acid salvage (GO:0043102) | 3.03245690 |
107 | L-methionine salvage (GO:0071267) | 3.03245690 |
108 | L-methionine biosynthetic process (GO:0071265) | 3.03245690 |
109 | DNA replication-independent nucleosome organization (GO:0034724) | 3.02151557 |
110 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.02151557 |
111 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.00081470 |
112 | telomere maintenance via telomere lengthening (GO:0010833) | 2.97667890 |
113 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.97170546 |
114 | apoptotic cell clearance (GO:0043277) | 2.96759169 |
115 | rRNA methylation (GO:0031167) | 2.96419852 |
116 | DNA-templated transcription, elongation (GO:0006354) | 2.95613883 |
117 | epithelial cell-cell adhesion (GO:0090136) | 2.95414900 |
118 | low-density lipoprotein particle clearance (GO:0034383) | 2.93256954 |
119 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.92964328 |
120 | hypotonic response (GO:0006971) | 2.91717650 |
121 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.90470138 |
122 | NADPH regeneration (GO:0006740) | 2.90143944 |
123 | positive regulation of cell cycle arrest (GO:0071158) | 2.90107261 |
124 | establishment of chromosome localization (GO:0051303) | 2.89499212 |
125 | desmosome organization (GO:0002934) | 2.89430294 |
126 | viral life cycle (GO:0019058) | 2.87932251 |
127 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.87599923 |
128 | positive regulation of viral transcription (GO:0050434) | 2.87156431 |
129 | protein neddylation (GO:0045116) | 2.86449411 |
130 | positive regulation of receptor recycling (GO:0001921) | 2.86156150 |
131 | hyaluronan catabolic process (GO:0030214) | 2.85767517 |
132 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.85296160 |
133 | glycosphingolipid catabolic process (GO:0046479) | 2.85087261 |
134 | glucose catabolic process (GO:0006007) | 2.82661555 |
135 | glucose 6-phosphate metabolic process (GO:0051156) | 2.82534031 |
136 | activation of Rac GTPase activity (GO:0032863) | 2.82486646 |
137 | positive regulation of extracellular matrix organization (GO:1903055) | 2.79023600 |
138 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.79016458 |
139 | regulation of superoxide anion generation (GO:0032928) | 2.76426222 |
140 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.76242120 |
141 | maternal placenta development (GO:0001893) | 2.75334499 |
142 | positive regulation of nuclease activity (GO:0032075) | 2.75150543 |
143 | peptidyl-proline hydroxylation (GO:0019511) | 2.74339903 |
144 | vesicle coating (GO:0006901) | 2.74265875 |
145 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69071717 |
146 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.66609416 |
147 | cellular copper ion homeostasis (GO:0006878) | 2.66295312 |
148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65581683 |
149 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.64950950 |
150 | response to laminar fluid shear stress (GO:0034616) | 2.64464363 |
151 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.63882389 |
152 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.61704865 |
153 | protein hydroxylation (GO:0018126) | 2.61696038 |
154 | membrane raft organization (GO:0031579) | 2.60762638 |
155 | embryonic process involved in female pregnancy (GO:0060136) | 2.58930215 |
156 | modulation by symbiont of host cellular process (GO:0044068) | 2.58548574 |
157 | proline biosynthetic process (GO:0006561) | 2.56697497 |
158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51966078 |
159 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.51686807 |
160 | negative regulation of cell size (GO:0045792) | 2.50884557 |
161 | apoptotic process involved in morphogenesis (GO:0060561) | 2.49077856 |
162 | glycolipid catabolic process (GO:0019377) | 2.48313391 |
163 | embryo implantation (GO:0007566) | 2.48261207 |
164 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46964220 |
165 | ER-nucleus signaling pathway (GO:0006984) | 2.46497869 |
166 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.45223964 |
167 | endodermal cell differentiation (GO:0035987) | 2.45040351 |
168 | regulation of nuclease activity (GO:0032069) | 2.44127712 |
169 | regulation of leukocyte degranulation (GO:0043300) | 2.44029478 |
170 | modulation by virus of host morphology or physiology (GO:0019048) | 2.41407582 |
171 | membrane protein ectodomain proteolysis (GO:0006509) | 2.40635489 |
172 | cellular response to unfolded protein (GO:0034620) | 2.40049286 |
173 | amyloid precursor protein catabolic process (GO:0042987) | 2.39708005 |
174 | mannose metabolic process (GO:0006013) | 2.39618329 |
175 | semaphorin-plexin signaling pathway (GO:0071526) | 2.37740666 |
176 | substrate-dependent cell migration (GO:0006929) | 2.37631265 |
177 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37094935 |
178 | cortical actin cytoskeleton organization (GO:0030866) | 2.36149739 |
179 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34539935 |
180 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.31010088 |
181 | actin filament bundle assembly (GO:0051017) | 2.30177596 |
182 | actin filament bundle organization (GO:0061572) | 2.30177596 |
183 | response to thyroid hormone (GO:0097066) | 2.29060891 |
184 | amino sugar catabolic process (GO:0046348) | 2.28669277 |
185 | neutrophil activation involved in immune response (GO:0002283) | 2.28025209 |
186 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.27791939 |
187 | pyrimidine-containing compound salvage (GO:0008655) | 2.27413367 |
188 | pyrimidine nucleoside salvage (GO:0043097) | 2.27413367 |
189 | regulation of defense response to virus by virus (GO:0050690) | 2.26695177 |
190 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.26509246 |
191 | positive regulation of leukocyte degranulation (GO:0043302) | 2.25108081 |
192 | oligosaccharide catabolic process (GO:0009313) | 2.24899969 |
193 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.24776896 |
194 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.24388159 |
195 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.24388159 |
196 | modulation by symbiont of host immune response (GO:0052553) | 2.24388159 |
197 | positive regulation by symbiont of host defense response (GO:0052509) | 2.24388159 |
198 | modulation by symbiont of host defense response (GO:0052031) | 2.24388159 |
199 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.24388159 |
200 | modulation by virus of host process (GO:0019054) | 2.23004252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.63642036 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.56501335 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.15618737 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.14293700 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.04032648 |
6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.76915771 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.64378003 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.62028191 |
9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.47047173 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.45784872 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.26537417 |
12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.03135094 |
13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.02611325 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00293581 |
15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93268731 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.92737837 |
17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.85353357 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84128096 |
19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.83317848 |
20 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.81652505 |
21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.72855774 |
22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.71841872 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70227509 |
24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.67520743 |
25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61531978 |
26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.56574848 |
27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.55016912 |
28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.50664157 |
29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.42019948 |
30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.41684542 |
31 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.38791009 |
32 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.33378486 |
33 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.29268843 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27332361 |
35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.26294373 |
36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.24409636 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21661204 |
38 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.18463732 |
39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18222282 |
40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.14766537 |
41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13085427 |
42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.10930037 |
43 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05915031 |
44 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.03841971 |
45 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.02510968 |
46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97721223 |
47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.95993845 |
48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.95132189 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94679006 |
50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.92365949 |
51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.90674176 |
52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.90023136 |
53 | MYC_22102868_ChIP-Seq_BL_Human | 1.84478155 |
54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.81969749 |
55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.80168268 |
56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79582880 |
57 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.78527817 |
58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77608067 |
59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77562702 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76664667 |
61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76584109 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75578448 |
63 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.70774457 |
64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70399549 |
65 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70270938 |
66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.69106474 |
67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66107539 |
68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65889984 |
69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65614734 |
70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.62882120 |
71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62525517 |
72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60113678 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58785481 |
74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58225142 |
75 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.53023633 |
76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49869426 |
77 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49839494 |
78 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49565200 |
79 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48401059 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48378517 |
81 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46149397 |
82 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43628133 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43121101 |
84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42951644 |
85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42800246 |
86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42734693 |
87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42124931 |
88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41375256 |
89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39145583 |
90 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39080660 |
91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38696970 |
92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38574061 |
93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38191461 |
94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37564037 |
95 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.36217402 |
96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36106123 |
97 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.35820938 |
98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35324366 |
99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32860939 |
100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31581207 |
101 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31084304 |
102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31030608 |
103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30043240 |
104 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29106011 |
105 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.28213984 |
106 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27908698 |
107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27350509 |
108 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25432358 |
109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24849600 |
110 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23203410 |
111 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22491379 |
112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21996096 |
113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20951008 |
114 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.20865825 |
115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20603282 |
116 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20546217 |
117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18820706 |
118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18820706 |
119 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17558554 |
120 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16917820 |
121 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16289653 |
122 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15035821 |
123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14793669 |
124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14373494 |
125 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13884626 |
126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12642816 |
127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12057590 |
128 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11886365 |
129 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11770810 |
130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11358253 |
131 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11268436 |
132 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.10255618 |
133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10217657 |
134 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.09853637 |
135 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09761948 |
136 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09201472 |
137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09175991 |
138 | MAF_26560356_Chip-Seq_TH1_Human | 1.08301465 |
139 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08281650 |
140 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07982380 |
141 | P68_20966046_ChIP-Seq_HELA_Human | 1.07353379 |
142 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06528145 |
143 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05622089 |
144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04886761 |
145 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04031356 |
146 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03699095 |
147 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03206548 |
148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02480568 |
149 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01489423 |
150 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99958798 |
151 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99786055 |
152 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99383257 |
153 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99212237 |
154 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98874170 |
155 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98173924 |
156 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97539671 |
157 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97130860 |
158 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96369751 |
159 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95832071 |
160 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95121600 |
161 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.94924649 |
162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94656214 |
163 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94295432 |
164 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93887528 |
165 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89491931 |
166 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89435319 |
167 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89394444 |
168 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87395931 |
169 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87177697 |
170 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82934661 |
171 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.81729082 |
172 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80887261 |
173 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.80488228 |
174 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.79712509 |
175 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.79009608 |
176 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.77487217 |
177 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.76498716 |
178 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76415470 |
179 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.76062495 |
180 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73513819 |
181 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73288828 |
182 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72469431 |
183 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.72320859 |
184 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.72091028 |
185 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.71268550 |
186 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.70337331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 5.15202615 |
2 | MP0003705_abnormal_hypodermis_morpholog | 4.53051723 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.75524683 |
4 | MP0008057_abnormal_DNA_replication | 3.61074032 |
5 | MP0005058_abnormal_lysosome_morphology | 3.57173273 |
6 | MP0010094_abnormal_chromosome_stability | 3.35909469 |
7 | MP0003123_paternal_imprinting | 3.26764974 |
8 | MP0003566_abnormal_cell_adhesion | 3.19574913 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.19494217 |
10 | MP0003077_abnormal_cell_cycle | 3.16132656 |
11 | MP0003111_abnormal_nucleus_morphology | 3.10992729 |
12 | MP0002877_abnormal_melanocyte_morpholog | 3.06075703 |
13 | MP0008058_abnormal_DNA_repair | 3.05081280 |
14 | MP0008007_abnormal_cellular_replicative | 2.87167593 |
15 | MP0008932_abnormal_embryonic_tissue | 2.81616284 |
16 | MP0005451_abnormal_body_composition | 2.68283990 |
17 | MP0003718_maternal_effect | 2.64376846 |
18 | MP0009840_abnormal_foam_cell | 2.55392728 |
19 | MP0005257_abnormal_intraocular_pressure | 2.25872931 |
20 | MP0000858_altered_metastatic_potential | 2.09608049 |
21 | MP0004272_abnormal_basement_membrane | 2.08302516 |
22 | MP0001849_ear_inflammation | 2.03865734 |
23 | MP0010234_abnormal_vibrissa_follicle | 2.02961474 |
24 | MP0001542_abnormal_bone_strength | 1.96892492 |
25 | MP0003436_decreased_susceptibility_to | 1.94758951 |
26 | MP0002163_abnormal_gland_morphology | 1.91319717 |
27 | MP0003453_abnormal_keratinocyte_physiol | 1.91275998 |
28 | MP0005076_abnormal_cell_differentiation | 1.89867609 |
29 | MP0003186_abnormal_redox_activity | 1.88479914 |
30 | MP0003172_abnormal_lysosome_physiology | 1.87577826 |
31 | MP0003136_yellow_coat_color | 1.87446506 |
32 | MP0005023_abnormal_wound_healing | 1.84200626 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.83626861 |
34 | MP0003786_premature_aging | 1.83328196 |
35 | MP0004233_abnormal_muscle_weight | 1.79716532 |
36 | MP0003091_abnormal_cell_migration | 1.75946807 |
37 | MP0003300_gastrointestinal_ulcer | 1.75917660 |
38 | MP0004858_abnormal_nervous_system | 1.75127722 |
39 | MP0002938_white_spotting | 1.74264897 |
40 | MP0000372_irregular_coat_pigmentation | 1.73185700 |
41 | MP0002796_impaired_skin_barrier | 1.72841380 |
42 | MP0002132_abnormal_respiratory_system | 1.68557539 |
43 | MP0002060_abnormal_skin_morphology | 1.66851906 |
44 | MP0009697_abnormal_copulation | 1.65307387 |
45 | MP0001958_emphysema | 1.55492172 |
46 | MP0003121_genomic_imprinting | 1.55172345 |
47 | MP0008260_abnormal_autophagy | 1.55027182 |
48 | MP0003315_abnormal_perineum_morphology | 1.54169867 |
49 | MP0008877_abnormal_DNA_methylation | 1.51684455 |
50 | MP0001730_embryonic_growth_arrest | 1.51260744 |
51 | MP0010352_gastrointestinal_tract_polyps | 1.50702494 |
52 | MP0000350_abnormal_cell_proliferation | 1.48610302 |
53 | MP0003303_peritoneal_inflammation | 1.48517675 |
54 | MP0003941_abnormal_skin_development | 1.46966082 |
55 | MP0003950_abnormal_plasma_membrane | 1.45568994 |
56 | MP0000566_synostosis | 1.42406948 |
57 | MP0003329_amyloid_beta_deposits | 1.39977214 |
58 | MP0003075_altered_response_to | 1.39336510 |
59 | MP0002160_abnormal_reproductive_system | 1.37207172 |
60 | MP0004947_skin_inflammation | 1.37177862 |
61 | MP0005409_darkened_coat_color | 1.35462445 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.35430549 |
63 | MP0009333_abnormal_splenocyte_physiolog | 1.34876011 |
64 | MP0000343_altered_response_to | 1.34835161 |
65 | MP0005501_abnormal_skin_physiology | 1.34778854 |
66 | MP0002396_abnormal_hematopoietic_system | 1.31947007 |
67 | MP0004147_increased_porphyrin_level | 1.30484987 |
68 | MP0001533_abnormal_skeleton_physiology | 1.28465167 |
69 | MP0003828_pulmonary_edema | 1.26119617 |
70 | MP0009379_abnormal_foot_pigmentation | 1.25239991 |
71 | MP0005464_abnormal_platelet_physiology | 1.24654490 |
72 | MP0002998_abnormal_bone_remodeling | 1.23070754 |
73 | MP0005379_endocrine/exocrine_gland_phen | 1.21706506 |
74 | MP0005275_abnormal_skin_tensile | 1.20328829 |
75 | MP0000767_abnormal_smooth_muscle | 1.19774999 |
76 | MP0002210_abnormal_sex_determination | 1.19341282 |
77 | MP0001216_abnormal_epidermal_layer | 1.17045148 |
78 | MP0004264_abnormal_extraembryonic_tissu | 1.16410388 |
79 | MP0006054_spinal_hemorrhage | 1.15080222 |
80 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14592478 |
81 | MP0003448_altered_tumor_morphology | 1.14326696 |
82 | MP0005623_abnormal_meninges_morphology | 1.13353465 |
83 | MP0009278_abnormal_bone_marrow | 1.13318737 |
84 | MP0000604_amyloidosis | 1.13044112 |
85 | MP0001293_anophthalmia | 1.12899601 |
86 | MP0002419_abnormal_innate_immunity | 1.12357914 |
87 | MP0003937_abnormal_limbs/digits/tail_de | 1.11922968 |
88 | MP0005380_embryogenesis_phenotype | 1.09511523 |
89 | MP0001672_abnormal_embryogenesis/_devel | 1.09511523 |
90 | MP0001915_intracranial_hemorrhage | 1.08704518 |
91 | MP0006292_abnormal_olfactory_placode | 1.05872792 |
92 | MP0002896_abnormal_bone_mineralization | 1.05647361 |
93 | MP0005389_reproductive_system_phenotype | 1.05055113 |
94 | MP0004510_myositis | 1.04435288 |
95 | MP0005164_abnormal_response_to | 1.03949213 |
96 | MP0001119_abnormal_female_reproductive | 1.03224334 |
97 | MP0001697_abnormal_embryo_size | 1.02509027 |
98 | MP0002080_prenatal_lethality | 1.00558451 |
99 | MP0000313_abnormal_cell_death | 1.00517626 |
100 | MP0008438_abnormal_cutaneous_collagen | 1.00050249 |
101 | MP0000751_myopathy | 0.99349093 |
102 | MP0003984_embryonic_growth_retardation | 0.98643970 |
103 | MP0006082_CNS_inflammation | 0.98559651 |
104 | MP0005165_increased_susceptibility_to | 0.98136024 |
105 | MP0009053_abnormal_anal_canal | 0.98117021 |
106 | MP0008789_abnormal_olfactory_epithelium | 0.96723829 |
107 | MP0000747_muscle_weakness | 0.96181814 |
108 | MP0002088_abnormal_embryonic_growth/wei | 0.94750306 |
109 | MP0001853_heart_inflammation | 0.94015240 |
110 | MP0005621_abnormal_cell_physiology | 0.93807262 |
111 | MP0000003_abnormal_adipose_tissue | 0.93733152 |
112 | MP0000733_abnormal_muscle_development | 0.93407151 |
113 | MP0001243_abnormal_dermal_layer | 0.93146344 |
114 | MP0003938_abnormal_ear_development | 0.92742472 |
115 | MP0000490_abnormal_crypts_of | 0.92360509 |
116 | MP0001905_abnormal_dopamine_level | 0.92105536 |
117 | MP0005503_abnormal_tendon_morphology | 0.91079017 |
118 | MP0002085_abnormal_embryonic_tissue | 0.90598670 |
119 | MP0009250_abnormal_appendicular_skeleto | 0.90041345 |
120 | MP0002089_abnormal_postnatal_growth/wei | 0.89926190 |
121 | MP0010368_abnormal_lymphatic_system | 0.87267460 |
122 | MP0001145_abnormal_male_reproductive | 0.86647657 |
123 | MP0005390_skeleton_phenotype | 0.86415727 |
124 | MP0000049_abnormal_middle_ear | 0.86392091 |
125 | MP0000653_abnormal_sex_gland | 0.85639464 |
126 | MP0005508_abnormal_skeleton_morphology | 0.85514314 |
127 | MP0003942_abnormal_urinary_system | 0.85513923 |
128 | MP0005377_hearing/vestibular/ear_phenot | 0.84321458 |
129 | MP0003878_abnormal_ear_physiology | 0.84321458 |
130 | MP0005375_adipose_tissue_phenotype | 0.84287417 |
131 | MP0000750_abnormal_muscle_regeneration | 0.83782796 |
132 | MP0000467_abnormal_esophagus_morphology | 0.83295613 |
133 | MP0010030_abnormal_orbit_morphology | 0.82601775 |
134 | MP0001986_abnormal_taste_sensitivity | 0.81301287 |
135 | MP0001348_abnormal_lacrimal_gland | 0.80649783 |
136 | MP0001529_abnormal_vocalization | 0.80214059 |
137 | MP0000678_abnormal_parathyroid_gland | 0.79455722 |
138 | MP0009931_abnormal_skin_appearance | 0.78862727 |
139 | MP0004782_abnormal_surfactant_physiolog | 0.78502906 |
140 | MP0000681_abnormal_thyroid_gland | 0.78482948 |
141 | MP0001485_abnormal_pinna_reflex | 0.78417061 |
142 | MP0005666_abnormal_adipose_tissue | 0.78254517 |
143 | MP0005025_abnormal_response_to | 0.77802584 |
144 | MP0002019_abnormal_tumor_incidence | 0.77403101 |
145 | MP0003795_abnormal_bone_structure | 0.76551256 |
146 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74548539 |
147 | MP0000762_abnormal_tongue_morphology | 0.71682857 |
148 | MP0005395_other_phenotype | 0.69819288 |
149 | MP0000537_abnormal_urethra_morphology | 0.68861530 |
150 | MP0000759_abnormal_skeletal_muscle | 0.68424408 |
151 | MP0000358_abnormal_cell_content/ | 0.67692773 |
152 | MP0010771_integument_phenotype | 0.67610218 |
153 | MP0003936_abnormal_reproductive_system | 0.67176243 |
154 | MP0003183_abnormal_peptide_metabolism | 0.66802367 |
155 | MP0001286_abnormal_eye_development | 0.66799675 |
156 | MP0003755_abnormal_palate_morphology | 0.66761193 |
157 | MP0002148_abnormal_hypersensitivity_rea | 0.66458965 |
158 | MP0002751_abnormal_autonomic_nervous | 0.65984600 |
159 | MP0001851_eye_inflammation | 0.65876880 |
160 | MP0002098_abnormal_vibrissa_morphology | 0.65348081 |
161 | MP0001929_abnormal_gametogenesis | 0.65323994 |
162 | MP0005384_cellular_phenotype | 0.64907937 |
163 | MP0005397_hematopoietic_system_phenotyp | 0.64640945 |
164 | MP0001545_abnormal_hematopoietic_system | 0.64640945 |
165 | MP0004134_abnormal_chest_morphology | 0.64151233 |
166 | MP0002127_abnormal_cardiovascular_syste | 0.63988382 |
167 | MP0000516_abnormal_urinary_system | 0.62851466 |
168 | MP0005367_renal/urinary_system_phenotyp | 0.62851466 |
169 | MP0002638_abnormal_pupillary_reflex | 0.62681040 |
170 | MP0000579_abnormal_nail_morphology | 0.62248464 |
171 | MP0005330_cardiomyopathy | 0.62128554 |
172 | MP0004197_abnormal_fetal_growth/weight/ | 0.62115100 |
173 | MP0001614_abnormal_blood_vessel | 0.61833108 |
174 | MP0005408_hypopigmentation | 0.61692982 |
175 | MP0003279_aneurysm | 0.60956701 |
176 | MP0002086_abnormal_extraembryonic_tissu | 0.60859493 |
177 | MP0000428_abnormal_craniofacial_morphol | 0.60019215 |
178 | MP0005075_abnormal_melanosome_morpholog | 0.59345103 |
179 | MP0006036_abnormal_mitochondrial_physio | 0.59097036 |
180 | MP0004084_abnormal_cardiac_muscle | 0.58710027 |
181 | MP0001346_abnormal_lacrimal_gland | 0.57583396 |
182 | MP0004133_heterotaxia | 0.57044700 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 4.52034581 |
2 | Birth length less than 3rd percentile (HP:0003561) | 4.07452623 |
3 | Protrusio acetabuli (HP:0003179) | 4.04088191 |
4 | Vertebral compression fractures (HP:0002953) | 3.82201280 |
5 | Breast hypoplasia (HP:0003187) | 3.66269223 |
6 | Cerebral hypomyelination (HP:0006808) | 3.46685287 |
7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.45843525 |
8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.39886195 |
9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.39886195 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.39886195 |
11 | Reticulocytopenia (HP:0001896) | 3.32635527 |
12 | Abnormal number of erythroid precursors (HP:0012131) | 3.27713196 |
13 | Patellar aplasia (HP:0006443) | 2.97338414 |
14 | Cervical subluxation (HP:0003308) | 2.89012127 |
15 | Abnormality of glycolysis (HP:0004366) | 2.85085366 |
16 | Increased serum pyruvate (HP:0003542) | 2.85085366 |
17 | Aplastic anemia (HP:0001915) | 2.82781260 |
18 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.81799053 |
19 | Rough bone trabeculation (HP:0100670) | 2.76291123 |
20 | Type I transferrin isoform profile (HP:0003642) | 2.76204198 |
21 | Dysostosis multiplex (HP:0000943) | 2.74328743 |
22 | Distal lower limb muscle weakness (HP:0009053) | 2.72655225 |
23 | Pancreatic fibrosis (HP:0100732) | 2.72414119 |
24 | Carpal bone hypoplasia (HP:0001498) | 2.70338629 |
25 | Cerebral aneurysm (HP:0004944) | 2.69333391 |
26 | Acute necrotizing encephalopathy (HP:0006965) | 2.69298478 |
27 | Irregular epiphyses (HP:0010582) | 2.65654241 |
28 | Achilles tendon contracture (HP:0001771) | 2.65497685 |
29 | Increased connective tissue (HP:0009025) | 2.65058255 |
30 | Respiratory difficulties (HP:0002880) | 2.62910597 |
31 | Hyperacusis (HP:0010780) | 2.62415859 |
32 | Mitochondrial inheritance (HP:0001427) | 2.62353840 |
33 | Distal lower limb amyotrophy (HP:0008944) | 2.59223885 |
34 | Short nail (HP:0001799) | 2.58086734 |
35 | Distal upper limb amyotrophy (HP:0007149) | 2.57593548 |
36 | Upper limb amyotrophy (HP:0009129) | 2.57593548 |
37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.56328719 |
38 | Hepatocellular necrosis (HP:0001404) | 2.51796686 |
39 | Supernumerary spleens (HP:0009799) | 2.49392334 |
40 | Adrenal hypoplasia (HP:0000835) | 2.48936156 |
41 | Macrocytic anemia (HP:0001972) | 2.47954344 |
42 | Increased CSF lactate (HP:0002490) | 2.45900502 |
43 | Stenosis of the external auditory canal (HP:0000402) | 2.45420234 |
44 | Abnormality of the umbilical cord (HP:0010881) | 2.45355470 |
45 | Axonal loss (HP:0003447) | 2.44873785 |
46 | Atrophic scars (HP:0001075) | 2.43230736 |
47 | Fragile skin (HP:0001030) | 2.42962540 |
48 | Abnormality of the Achilles tendon (HP:0005109) | 2.41948893 |
49 | Myocardial infarction (HP:0001658) | 2.39733508 |
50 | Increased cerebral lipofuscin (HP:0011813) | 2.38995506 |
51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38779308 |
52 | Arterial tortuosity (HP:0005116) | 2.38720187 |
53 | Vascular tortuosity (HP:0004948) | 2.37580858 |
54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37234617 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.37234617 |
56 | True hermaphroditism (HP:0010459) | 2.37056782 |
57 | Degeneration of anterior horn cells (HP:0002398) | 2.35696785 |
58 | Abnormality of the anterior horn cell (HP:0006802) | 2.35696785 |
59 | Broad face (HP:0000283) | 2.34874999 |
60 | Abnormal trabecular bone morphology (HP:0100671) | 2.34478841 |
61 | Impulsivity (HP:0100710) | 2.34079662 |
62 | Selective tooth agenesis (HP:0001592) | 2.33388640 |
63 | Mucopolysacchariduria (HP:0008155) | 2.33250405 |
64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33250405 |
65 | Deep venous thrombosis (HP:0002625) | 2.32573394 |
66 | Abnormality of macrophages (HP:0004311) | 2.30232605 |
67 | Oral leukoplakia (HP:0002745) | 2.30184747 |
68 | Spinal rigidity (HP:0003306) | 2.30142075 |
69 | Ankle contracture (HP:0006466) | 2.29657601 |
70 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.29230485 |
71 | Short middle phalanx of the 5th finger (HP:0004220) | 2.29203704 |
72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28075587 |
73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28075587 |
74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28075587 |
75 | Hypoplastic left heart (HP:0004383) | 2.27461283 |
76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26206612 |
77 | Loss of speech (HP:0002371) | 2.25262626 |
78 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.24295847 |
79 | Hepatic necrosis (HP:0002605) | 2.23198945 |
80 | Increased serum lactate (HP:0002151) | 2.21341797 |
81 | Secondary amenorrhea (HP:0000869) | 2.20569317 |
82 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18732367 |
83 | Flat acetabular roof (HP:0003180) | 2.18483453 |
84 | Colon cancer (HP:0003003) | 2.17899659 |
85 | Neurofibrillary tangles (HP:0002185) | 2.17136826 |
86 | Diastasis recti (HP:0001540) | 2.15822067 |
87 | Progressive macrocephaly (HP:0004481) | 2.15797256 |
88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.14330709 |
89 | Abnormality of the columella (HP:0009929) | 2.14162808 |
90 | Pancreatic cysts (HP:0001737) | 2.13738368 |
91 | Blue sclerae (HP:0000592) | 2.12866060 |
92 | Nuclear cataract (HP:0100018) | 2.12386393 |
93 | Poor head control (HP:0002421) | 2.11636356 |
94 | Lipid accumulation in hepatocytes (HP:0006561) | 2.11487189 |
95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.11320080 |
96 | Dilatation of the ascending aorta (HP:0005111) | 2.10088113 |
97 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.09651507 |
98 | Single umbilical artery (HP:0001195) | 2.09651507 |
99 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.09651507 |
100 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09059587 |
101 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09059587 |
102 | Abnormal protein glycosylation (HP:0012346) | 2.09059587 |
103 | Abnormal glycosylation (HP:0012345) | 2.09059587 |
104 | Microvesicular hepatic steatosis (HP:0001414) | 2.08886042 |
105 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.08636506 |
106 | Amyloidosis (HP:0011034) | 2.07499571 |
107 | Hand muscle atrophy (HP:0009130) | 2.07333871 |
108 | Absent radius (HP:0003974) | 2.07041010 |
109 | Pallor (HP:0000980) | 2.06771911 |
110 | Aortic dissection (HP:0002647) | 2.06694371 |
111 | Flat capital femoral epiphysis (HP:0003370) | 2.06642630 |
112 | Trismus (HP:0000211) | 2.06019039 |
113 | Cerebral inclusion bodies (HP:0100314) | 2.05018585 |
114 | Metaphyseal dysplasia (HP:0100255) | 2.02926237 |
115 | Sparse eyelashes (HP:0000653) | 2.02661718 |
116 | Nasolacrimal duct obstruction (HP:0000579) | 2.02210401 |
117 | Hypoplastic heart (HP:0001961) | 2.01294956 |
118 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.01224244 |
119 | Cholecystitis (HP:0001082) | 2.00015203 |
120 | Abnormal gallbladder physiology (HP:0012438) | 2.00015203 |
121 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.99673107 |
122 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.99673107 |
123 | Vacuolated lymphocytes (HP:0001922) | 1.99526760 |
124 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.99355153 |
125 | Microretrognathia (HP:0000308) | 1.98949167 |
126 | Chromsome breakage (HP:0040012) | 1.97638690 |
127 | Natal tooth (HP:0000695) | 1.97104460 |
128 | Disproportionate tall stature (HP:0001519) | 1.97082687 |
129 | Wormian bones (HP:0002645) | 1.96219027 |
130 | Acute encephalopathy (HP:0006846) | 1.95610861 |
131 | Premature graying of hair (HP:0002216) | 1.94502621 |
132 | Abnormality of the renal collecting system (HP:0004742) | 1.94285700 |
133 | Insomnia (HP:0100785) | 1.94185610 |
134 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.93664739 |
135 | Meckel diverticulum (HP:0002245) | 1.93648875 |
136 | Thin bony cortex (HP:0002753) | 1.93415263 |
137 | Renal Fanconi syndrome (HP:0001994) | 1.93117077 |
138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92691981 |
139 | Prolonged neonatal jaundice (HP:0006579) | 1.92467441 |
140 | Generalized amyotrophy (HP:0003700) | 1.91594749 |
141 | Asymmetry of the thorax (HP:0001555) | 1.91359087 |
142 | Aneurysm (HP:0002617) | 1.91091723 |
143 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.90970286 |
144 | Mitral regurgitation (HP:0001653) | 1.90685197 |
145 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.90420300 |
146 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.90052302 |
147 | Patent foramen ovale (HP:0001655) | 1.89644782 |
148 | Eczematoid dermatitis (HP:0000976) | 1.89495018 |
149 | Absent forearm bone (HP:0003953) | 1.88905407 |
150 | Aplasia involving forearm bones (HP:0009822) | 1.88905407 |
151 | Elbow flexion contracture (HP:0002987) | 1.88432681 |
152 | Peritonitis (HP:0002586) | 1.88375031 |
153 | Long palpebral fissure (HP:0000637) | 1.88296569 |
154 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88261480 |
155 | Postnatal microcephaly (HP:0005484) | 1.87933547 |
156 | Ureteral duplication (HP:0000073) | 1.86475291 |
157 | Abnormal lung lobation (HP:0002101) | 1.86271388 |
158 | J-shaped sella turcica (HP:0002680) | 1.85594004 |
159 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85590005 |
160 | Biconcave vertebral bodies (HP:0004586) | 1.85567547 |
161 | Upper motor neuron abnormality (HP:0002127) | 1.85424061 |
162 | Difficulty climbing stairs (HP:0003551) | 1.85297171 |
163 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.84906110 |
164 | Ulnar bowing (HP:0003031) | 1.84368651 |
165 | Bladder diverticulum (HP:0000015) | 1.84286699 |
166 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82978484 |
167 | Abnormality of carpal bone ossification (HP:0006257) | 1.82945186 |
168 | Mitral stenosis (HP:0001718) | 1.82877221 |
169 | Hypoplasia of the uterus (HP:0000013) | 1.82134053 |
170 | Muscle fiber atrophy (HP:0100295) | 1.81245229 |
171 | Interstitial pulmonary disease (HP:0006530) | 1.80102251 |
172 | CNS hypomyelination (HP:0003429) | 1.79978736 |
173 | Triphalangeal thumb (HP:0001199) | 1.79964300 |
174 | Exercise intolerance (HP:0003546) | 1.79959535 |
175 | Abnormality of the ileum (HP:0001549) | 1.79290692 |
176 | Respiratory failure (HP:0002878) | 1.78976045 |
177 | Horseshoe kidney (HP:0000085) | 1.78875397 |
178 | Shallow orbits (HP:0000586) | 1.78546417 |
179 | Lower limb amyotrophy (HP:0007210) | 1.78081330 |
180 | Abnormality of the acetabulum (HP:0003170) | 1.77883381 |
181 | Abnormal ossification of hand bones (HP:0005921) | 1.76855727 |
182 | Bone pain (HP:0002653) | 1.76362400 |
183 | Hemorrhage of the eye (HP:0011885) | 1.76257981 |
184 | Pathologic fracture (HP:0002756) | 1.74974159 |
185 | Aortic aneurysm (HP:0004942) | 1.74797206 |
186 | Syringomyelia (HP:0003396) | 1.74681446 |
187 | Spinal cord lesions (HP:0100561) | 1.74681446 |
188 | Back pain (HP:0003418) | 1.73013888 |
189 | Apathy (HP:0000741) | 1.72916825 |
190 | Supranuclear gaze palsy (HP:0000605) | 1.72674733 |
191 | Abnormality of oral frenula (HP:0000190) | 1.71315638 |
192 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70372075 |
193 | Ankyloglossia (HP:0010296) | 1.70112583 |
194 | Spondylolisthesis (HP:0003302) | 1.70082623 |
195 | Diminished motivation (HP:0000745) | 1.69808730 |
196 | Neuronal loss in central nervous system (HP:0002529) | 1.69529636 |
197 | Advanced eruption of teeth (HP:0006288) | 1.68405336 |
198 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67932907 |
199 | Abnormality of dentin (HP:0010299) | 1.64613749 |
200 | Recurrent abscess formation (HP:0002722) | 1.63784775 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 4.65924454 |
2 | TRIB3 | 3.67060271 |
3 | WEE1 | 3.61954853 |
4 | ERN1 | 3.03863635 |
5 | EIF2AK1 | 3.02428202 |
6 | ACVR1B | 3.01354767 |
7 | STK16 | 2.98276992 |
8 | PRPF4B | 2.77092947 |
9 | PLK4 | 2.66545023 |
10 | NME2 | 2.57903345 |
11 | SRPK1 | 2.53779759 |
12 | SIK1 | 2.41283438 |
13 | SMG1 | 2.38319608 |
14 | TSSK6 | 2.34196849 |
15 | ICK | 2.20040954 |
16 | EIF2AK3 | 2.18833936 |
17 | BRSK2 | 2.17562206 |
18 | ZAK | 2.02343594 |
19 | MST1R | 1.97858033 |
20 | PDGFRA | 1.94801107 |
21 | PIM2 | 1.94282403 |
22 | VRK1 | 1.93516536 |
23 | MAP2K3 | 1.90163762 |
24 | RIPK1 | 1.85977309 |
25 | PBK | 1.83374813 |
26 | TTN | 1.81123321 |
27 | EPHB1 | 1.72314250 |
28 | PLK3 | 1.66679948 |
29 | PTK2 | 1.66379827 |
30 | MKNK1 | 1.62363255 |
31 | CDC7 | 1.61288580 |
32 | EPHA2 | 1.60488311 |
33 | PLK1 | 1.57284070 |
34 | DYRK3 | 1.56576976 |
35 | LATS2 | 1.51961344 |
36 | STK38L | 1.49118487 |
37 | SCYL2 | 1.48176492 |
38 | FGFR4 | 1.46907839 |
39 | IRAK3 | 1.42637894 |
40 | PKN2 | 1.41137604 |
41 | KSR2 | 1.35882374 |
42 | AKT3 | 1.35516425 |
43 | TTK | 1.35431574 |
44 | MUSK | 1.31027133 |
45 | MST4 | 1.30768748 |
46 | RPS6KB2 | 1.26845166 |
47 | BMPR1B | 1.25103198 |
48 | EEF2K | 1.24508094 |
49 | BRAF | 1.24434451 |
50 | ARAF | 1.24172762 |
51 | NEK9 | 1.23291714 |
52 | DYRK2 | 1.22069365 |
53 | TGFBR2 | 1.21578437 |
54 | CDK12 | 1.20400908 |
55 | TESK2 | 1.19439885 |
56 | AURKB | 1.19140514 |
57 | NUAK1 | 1.17781939 |
58 | LMTK2 | 1.17363250 |
59 | BRSK1 | 1.14420053 |
60 | BCR | 1.13486190 |
61 | SIK3 | 1.13407251 |
62 | PTK6 | 1.12838320 |
63 | TGFBR1 | 1.11570809 |
64 | MKNK2 | 1.09718986 |
65 | CDK8 | 1.08923106 |
66 | PASK | 1.03909543 |
67 | DDR2 | 1.03185227 |
68 | AURKA | 1.02888932 |
69 | NTRK1 | 1.02659559 |
70 | MAPKAPK3 | 0.99161226 |
71 | EIF2AK2 | 0.99091474 |
72 | ZAP70 | 0.98839246 |
73 | CDK7 | 0.97971006 |
74 | NEK2 | 0.97554405 |
75 | MAP3K1 | 0.95989124 |
76 | TLK1 | 0.94690406 |
77 | RPS6KA4 | 0.94576899 |
78 | LIMK1 | 0.92698661 |
79 | BMPR2 | 0.92684632 |
80 | STK24 | 0.91871626 |
81 | MAPKAPK5 | 0.90770859 |
82 | PRKD2 | 0.89466920 |
83 | TRPM7 | 0.88397675 |
84 | TAOK1 | 0.87625167 |
85 | CCNB1 | 0.86643936 |
86 | EPHB2 | 0.84357253 |
87 | CHEK2 | 0.82736190 |
88 | MAP3K13 | 0.82561289 |
89 | ATR | 0.82431010 |
90 | MAP3K6 | 0.82102026 |
91 | BMX | 0.81941528 |
92 | TBK1 | 0.81649506 |
93 | PDPK1 | 0.81116133 |
94 | TYK2 | 0.80593473 |
95 | STK38 | 0.80082695 |
96 | MTOR | 0.79738894 |
97 | CDC42BPA | 0.78917748 |
98 | ERBB3 | 0.78736009 |
99 | IRAK4 | 0.77117714 |
100 | PRKG2 | 0.76688526 |
101 | MYLK | 0.76197469 |
102 | RIPK4 | 0.74859178 |
103 | ILK | 0.74523468 |
104 | LRRK2 | 0.74385371 |
105 | NEK6 | 0.73231156 |
106 | IRAK2 | 0.72824970 |
107 | OBSCN | 0.72815651 |
108 | ERBB4 | 0.68267152 |
109 | STK10 | 0.67820736 |
110 | PDK2 | 0.67680659 |
111 | CSNK2A1 | 0.67551323 |
112 | MAP3K2 | 0.66643223 |
113 | CSK | 0.66610145 |
114 | NME1 | 0.65679246 |
115 | YES1 | 0.64227395 |
116 | FGR | 0.64192847 |
117 | RPS6KA5 | 0.60950590 |
118 | PAK1 | 0.60526817 |
119 | RPS6KA2 | 0.59371692 |
120 | IKBKB | 0.58833795 |
121 | PAK2 | 0.58781265 |
122 | PIM1 | 0.58366054 |
123 | MAP3K14 | 0.56639003 |
124 | MAP3K3 | 0.52681557 |
125 | KSR1 | 0.52609394 |
126 | NEK1 | 0.52357170 |
127 | MELK | 0.52311250 |
128 | CSNK2A2 | 0.52050549 |
129 | MAP3K9 | 0.51979674 |
130 | STK4 | 0.51774376 |
131 | MARK2 | 0.51537821 |
132 | MOS | 0.51323045 |
133 | JAK3 | 0.51090825 |
134 | BLK | 0.50142284 |
135 | STK3 | 0.49201922 |
136 | RET | 0.47458258 |
137 | PDGFRB | 0.47099179 |
138 | TAOK2 | 0.46903072 |
139 | CDK6 | 0.46713669 |
140 | CHEK1 | 0.46623768 |
141 | MAPKAPK2 | 0.45564992 |
142 | MAP3K8 | 0.45024278 |
143 | ABL2 | 0.43460561 |
144 | MET | 0.42738005 |
145 | MAPK11 | 0.41013094 |
146 | FLT3 | 0.40948355 |
147 | CASK | 0.39283580 |
148 | STK39 | 0.36694368 |
149 | CSNK1G3 | 0.35915603 |
150 | CLK1 | 0.35674858 |
151 | PRKD3 | 0.35364058 |
152 | PRKCI | 0.34337218 |
153 | BCKDK | 0.34318667 |
154 | ALK | 0.34194730 |
155 | TESK1 | 0.34040620 |
156 | ATM | 0.33851494 |
157 | TIE1 | 0.33706372 |
158 | ROCK2 | 0.33531636 |
159 | KDR | 0.33440300 |
160 | RAF1 | 0.33193111 |
161 | LATS1 | 0.32285086 |
162 | MAP3K12 | 0.31619951 |
163 | CSF1R | 0.31357993 |
164 | CDK4 | 0.31193198 |
165 | RPS6KC1 | 0.31010773 |
166 | RPS6KL1 | 0.31010773 |
167 | PAK4 | 0.30921527 |
168 | DYRK1B | 0.30893283 |
169 | OXSR1 | 0.30706420 |
170 | CDK3 | 0.29823029 |
171 | MAP3K11 | 0.28732949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.53082692 |
2 | RNA polymerase_Homo sapiens_hsa03020 | 4.10879246 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.89209068 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.69034012 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 3.20006169 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.19900634 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.77573909 |
8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.71510984 |
9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.70888514 |
10 | Spliceosome_Homo sapiens_hsa03040 | 2.60192754 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.59838068 |
12 | Homologous recombination_Homo sapiens_hsa03440 | 2.57489852 |
13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.46345272 |
14 | Protein export_Homo sapiens_hsa03060 | 2.42808491 |
15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.31929443 |
16 | RNA transport_Homo sapiens_hsa03013 | 2.31720181 |
17 | Cell cycle_Homo sapiens_hsa04110 | 2.23375632 |
18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.21393846 |
19 | Bladder cancer_Homo sapiens_hsa05219 | 2.04706915 |
20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.01640378 |
21 | Lysosome_Homo sapiens_hsa04142 | 1.99769962 |
22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.83668776 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.83080894 |
24 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.71102401 |
25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.70057052 |
26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.69509342 |
27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69475028 |
28 | RNA degradation_Homo sapiens_hsa03018 | 1.67134562 |
29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.64169125 |
30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63527512 |
31 | Purine metabolism_Homo sapiens_hsa00230 | 1.63471233 |
32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58140662 |
33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56145648 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.54587561 |
35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54320081 |
36 | Prion diseases_Homo sapiens_hsa05020 | 1.53109140 |
37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45759857 |
38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.45039080 |
39 | Salmonella infection_Homo sapiens_hsa05132 | 1.43142991 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42983900 |
41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40319956 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40094042 |
43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38725514 |
44 | Focal adhesion_Homo sapiens_hsa04510 | 1.37951336 |
45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.37880055 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37185667 |
47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.35805678 |
48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28219680 |
49 | Amoebiasis_Homo sapiens_hsa05146 | 1.27854473 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26284360 |
51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25554933 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22625925 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21129482 |
54 | Endocytosis_Homo sapiens_hsa04144 | 1.20590514 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15645282 |
56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14737195 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13134572 |
58 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11585486 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08456251 |
60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06573497 |
61 | Adherens junction_Homo sapiens_hsa04520 | 1.06070118 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05895956 |
63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05109716 |
64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04211111 |
65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02582423 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.98140643 |
67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97293632 |
68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96247332 |
69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94786925 |
70 | Hepatitis B_Homo sapiens_hsa05161 | 0.94572936 |
71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94359856 |
72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93758224 |
73 | Glioma_Homo sapiens_hsa05214 | 0.93720895 |
74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92650687 |
75 | Tuberculosis_Homo sapiens_hsa05152 | 0.92090017 |
76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90225698 |
77 | Pertussis_Homo sapiens_hsa05133 | 0.90127076 |
78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89759703 |
79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88940332 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88515192 |
81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88033801 |
82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87322156 |
83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86747753 |
84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82301186 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80609445 |
86 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80603335 |
87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78734391 |
88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76128968 |
89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75988860 |
90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73918619 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73549985 |
92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73430651 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.73176531 |
94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73171951 |
95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72992363 |
96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71225417 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71119830 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70079981 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68750394 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68125527 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68066076 |
102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67121410 |
103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67001440 |
104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66912585 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66238201 |
106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66229038 |
107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65996958 |
108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63597374 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63222688 |
110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61096920 |
111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59549928 |
112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59302732 |
113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57884934 |
114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57186515 |
115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57050667 |
116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55327118 |
117 | Insulin resistance_Homo sapiens_hsa04931 | 0.53951373 |
118 | Legionellosis_Homo sapiens_hsa05134 | 0.53656625 |
119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53489621 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53476517 |
121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53305371 |
122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49805236 |
123 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49584602 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48632646 |
125 | Allograft rejection_Homo sapiens_hsa05330 | 0.48116607 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47381011 |
127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47356355 |
128 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47256143 |
129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46202348 |
130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44617182 |
131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44531551 |
132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42592564 |
133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42454126 |
134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41885965 |
135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37872316 |
136 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37178691 |
137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36711946 |
138 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.36309175 |
139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36018040 |
140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35824920 |
141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34427880 |
142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33111297 |
143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30423210 |
144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30355567 |
145 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28761679 |
146 | Apoptosis_Homo sapiens_hsa04210 | 0.28180093 |
147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27630745 |
148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26972959 |
149 | Shigellosis_Homo sapiens_hsa05131 | 0.26571691 |
150 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26424394 |
151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24795817 |
152 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22537514 |
153 | Malaria_Homo sapiens_hsa05144 | 0.20650530 |
154 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20611909 |
155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20316738 |
156 | Asthma_Homo sapiens_hsa05310 | 0.19797280 |
157 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19703065 |
158 | Tight junction_Homo sapiens_hsa04530 | 0.19700824 |
159 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19322824 |
160 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18994787 |
161 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17479425 |
162 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17374486 |
163 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.17093723 |
164 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.17089857 |
165 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15321480 |
166 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15291808 |
167 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.14714139 |
168 | Measles_Homo sapiens_hsa05162 | 0.12927604 |
169 | Phagosome_Homo sapiens_hsa04145 | 0.12588738 |
170 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.12423693 |
171 | Prostate cancer_Homo sapiens_hsa05215 | 0.12291457 |
172 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.11778405 |